Health Conditions

Symptoms Concerning Nutrition, Metabolism, and Development (phecode 1002)

2 variants Pharmacogenomic

Tacrolimus Response - Metabolism/pk

2 variants Pharmacogenomic

Warfarin Maintenance Dose (adjusted For Clinical Factors)

2 variants Pharmacogenomic

Auc of 2-hydroxy Atorvastatin

1 variant Pharmacogenomic

Auc of 4-hydroxy Atorvastatin

1 variant Pharmacogenomic

Auc of Atorvastatin Lactone

1 variant Pharmacogenomic

Auc of Simvastatin Acid

1 variant Pharmacogenomic

Caffeine Metabolism (plasma 3,7-dimethylxanthine (theobromine) Level)

1 variant Pharmacogenomic

Calpastatin Levels (cast.3026.5.2)

1 variant Pharmacogenomic

Carboplatin Drug Response (ic50)

1 variant Pharmacogenomic

Cerivastatin-induced Rhabdomyolysis

1 variant Pharmacogenomic

Cisplatin Drug Response (ic50)

1 variant Pharmacogenomic

Cmax of Atorvastatin

1 variant Pharmacogenomic

Cystatin B Plasma Levels

1 variant Pharmacogenomic

Cystatin-f (analyte X14038.130) Levels

1 variant Pharmacogenomic

Cystatin-like 1 Levels

1 variant Pharmacogenomic

Cystatin-m (analyte X14711.27) Levels

1 variant Pharmacogenomic

Cystatin-m (analyte X3303.23) Levels

1 variant Pharmacogenomic

Cystatin-m Levels (cst6.3303.23.2)

1 variant Pharmacogenomic

Daunorubicin Drug Response (ic50)

1 variant Pharmacogenomic

Disorders of Amino Acid Metabolism (phecode 270.2)

1 variant Pharmacogenomic

Disorders of Lipoid Metabolism (phecode 272)

1 variant Pharmacogenomic

Endostatin Plasma Levels

1 variant Pharmacogenomic

Follistatin-related Protein 1 Levels (fstl1.13112.179.3)

1 variant Pharmacogenomic

Follistatin-related Protein 4 Levels (fstl4.9350.3.3)

1 variant Pharmacogenomic

Follistatin-related Protein 5 Levels

1 variant Pharmacogenomic

Glomerular Filtration Rate (cystatin C)

1 variant Pharmacogenomic

Gut Microbial Functional Pathway Relative Abundance (kegg-module M00168: Cam (crassulacean Acid Metabolism), Dark)

1 variant Pharmacogenomic

Kallistatin (analyte X14105.5) Levels

1 variant Pharmacogenomic

Kallistatin (analyte X3449.58) Levels

1 variant Pharmacogenomic

Lipoprotein (a) Levels in Response to Niacin in Statin-treated Individuals

1 variant Pharmacogenomic

Low-density Lipoprotein Response to Statins (relative Logarithmic Difference)

1 variant Pharmacogenomic

Oncostatin-m-specific Receptor Subunit Beta Levels (osmr.10892.8.3)

1 variant Pharmacogenomic

Oncostatin-m-specific Receptor Subunit Beta Protein Levels (somascan Id:10512-13)

1 variant Pharmacogenomic

Other Disorders of Carbohydrate Transport and Metabolism (phecode 271.9)

1 variant Pharmacogenomic

Other Disorders of Metabolism (phecode 277)

1 variant Pharmacogenomic

Peak Plasma Concentration of Rosuvastatin

1 variant Pharmacogenomic

Pharmacokinetics of Antidepressant Drugs in Severe Mental Disorder (concentration Dose Ratio)

1 variant Pharmacogenomic

Plasma Concentration-time Curve of Rosuvastatin

1 variant Pharmacogenomic

Response to Clopidogrel Therapy

1 variant Pharmacogenomic

Treatment or Medication Use - Rosuvastatin (ukb Data Field 20003_1141192410)

1 variant Pharmacogenomic

Warfarin Dose Variability

1 variant Pharmacogenomic

Warfarin-associated Bleeding

1 variant Pharmacogenomic